Xpedilab Providers vs PhlebX - Phlebotomy @ Home Uso e estatísticas

The Xpedilab Providers app is the management-side application that allows partners on the Xpedilab platform to organize, assign, and complete blood draws for patients requesting mobile lab testing services. Administrators can manage their phlebotomy teams’ assignments and schedules using their administrator login and account. Mobile phlebotomists can see their patient assignments and schedules through their technician login and account, which allows for easy interaction with, and servicing of, patients on the Xpedilab app.
  • Apple App Store
  • Gratuitos
  • Médico

Ranking da Loja

- -

We are providing blood draw services to individuals and organizations, at the comfort of their home, at their community or onsite at their workplace. We offer same-day service that is available 24-hours a day / 7 days a week, whenever and wherever customers need them. Our team of registered Phlebotomists and Laboratory partners are fully licensed and certified in their respective states, and adhere to the industry’s highest professional standards. Our HIPPA-compliant technology platform increases operational efficiency and reliability, while our real-time digital/mobile technology improves significantly response times, cuts down on paperwork and human error rates, and secures patients’ data privacy.
  • Apple App Store
  • Gratuitos
  • Saúde e fitness

Ranking da Loja

- -

Xpedilab Providers versus PhlebX - Phlebotomy @ Home comparação de classificação

Compare a tendência de classificação de Xpedilab Providers nos últimos 28 dias versus PhlebX - Phlebotomy @ Home

Classificação

Nenhum dado disponível

Comparação da classificação de Xpedilab Providers vs. PhlebX - Phlebotomy @ Home por país

Compare a tendência de classificação de Xpedilab Providers nos últimos 28 dias versus PhlebX - Phlebotomy @ Home

Nenhum dado para exibir

Faça comparações com qualquer site com o nosso teste grátis

Comece agora
Xpedilab Providers VS.
PhlebX - Phlebotomy @ Home

14ezembro d, 2024